Dr. Alina Rwei engineers smart therapeutic and diagnostic platforms for next-generation precision therapies. Her long-term research goal is to bridge clinical translation with scientific discoveries by interfacing biology, materials science, and engineering in biomedical innovations that will make a long-lasting impact in patients’ lives. She aims to increase the effectiveness of drug delivery systems using chemical and materials engineering, electronic engineering and cell biology approaches. Current fields of focus include: light-, ultrasound- and magnetically-triggered therapeutics for alleviating pain and combatting cancer, wearable electronics for personalized real-time diagnostics, and study of nanoparticle and cellular interactions for designs of effective targeted delivery systems.
Dr. Rwei is an assistant professor in TU Delft. She received her undergraduate and Ph.D. degrees at the Massachusetts Institute of Technology, with her undergraduate degree in Chemical Engineering and Ph.D. degree in Materials Science and Engineering. Her Ph.D. training was conducted under the supervision of Professor Robert Langer at MIT and Professor Daniel Kohane at Harvard Medical School. She focused on the design and development of light- and ultrasound- triggerable drug delivery systems for repeatable and adjustable release of local anesthetics. She then proceeded to a postdoctoral position in Professor John Rogers’ lab at Northwestern University. She was the recipient of the Postdoctoral Fellowship Research Training Award (TL1) from the Clinical and Translational Science Awards Program by NIH/NCATS. Her experience has yielded publications in high-impact journals including Nature Medicine, Nature Biomedical Engineering, Proceedings of the National Academy of Sciences, Nano Letters, and Journal of Controlled Release. As a principle investigator in TU Delft, she aims to work at the interdisciplinary fields of precision medicine and chemical engineering, developing novel biomedical technologies for next-generation medicine.